YIELD10 BIOSCIENCE, INC.·4

Sep 29, 7:52 PM ET

HAASER CHARLES B 4

4 · YIELD10 BIOSCIENCE, INC. · Filed Sep 29, 2021

Insider Transaction Report

Form 4
Period: 2021-09-28
HAASER CHARLES B
Chief Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-28+18,00018,000 total
    Exercise: $6.30Exp: 2031-09-28Common Stock (18,000 underlying)
Footnotes (1)
  • [F1]These options will vest and become exercisable in equal quarterly installments over 4 years from 9/28/2021, beginning on 12/28/2021 and ending on 9/28/2025.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -